Authors: Ackerman, Margaret¹; Chalouni, Cecile²; Schmidt, Michael³; Raman, Vivek³; Ritter, Gerd⁴; Old, Lloyd⁴; Mellman, Ira²; Wittrup, K.⁵

Source: Cancer Immunology, Immunotherapy, Volume 57, Number 7, July 2008 , pp. 1017-1027(11)

Publisher: Springer

Abstract:

The A33 antigen is a cell surface glycoprotein of the small intestine and colonic epithelium with homology to tight junction-associated proteins of the immunoglobulin superfamily, including CAR and JAM. Its restricted tissue localization and high level of expression have led to its use as a target in colon cancer immunotherapy. Although the antigen is also present in normal intestine, radiolabeled antibodies against A33 are selectively retained by tumors in the gut as well as in metastatic lesions for as long as 6 weeks. Accordingly, we have studied the trafficking and kinetic properties of the antigen to determine its promise in two-step, pretargeted therapies. The localization, mobility, and persistence of the antigen were investigated, and this work has demonstrated that the antigen is both highly immobile and extremely persistent—retaining its surface localization for a turnover halflife of greater than 2 days. In order to explain these unusual properties, we explored the possibility that A33 is a component of the tight junction. The simple property of surface persistence, described here, may contribute to the prolonged retention of the clinically administered antibodies, and their uncommon ability to penetrate solid tumors.

Keywords: A33 antigen; Radioimmunotherapy; Colon cancer; Tight junction; Immunoglobulin superfamily

Document Type: Research article

DOI: http://dx.doi.org/10.1007/s00262-007-0433-x

Affiliations: 1: Department of Biology, Massachusetts Institute of Technology, Cambridge, USA 2: Department of Cell Biology, Ludwig Institute for Cancer Research, Yale University School of Medicine, New Haven, USA 3: Department of Biological Engineering, Massachusetts Institute of Technology, Bldg E19-551, 50 Ames Street, Cambridge, MA, 02139, USA 4: Ludwig Institute for Cancer Research, New York Branch, Memorial Sloan-Kettering Cancer Center, New York, USA 5: Department of Biological Engineering, Massachusetts Institute of Technology, Bldg E19-551, 50 Ames Street, Cambridge, MA, 02139, USA, Email: wittrup@mit.edu

Publication date: 2008-07-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Allergy & Immunology ,  Oncology
• By this author: Ackerman, Margaret ;  Chalouni, Cecile ;  Schmidt, Michael ;  Raman, Vivek ;  Ritter, Gerd ;  Old, Lloyd ;  Mellman, Ira ;  Wittrup, K.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers